- Conditions
- Peripheral Artery Disease, Vascular Disease, Critical Limb Ischemia
- Interventions
- Dexamethasone infusion, Drug coated balloon, Plain balloon angioplasty
- Drug · Device
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 35 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 2
- States / cities
- San Francisco, California • Seattle, Washington
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Critical Limb Ischemia
- Interventions
- FlowMet
- Device
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Critical Limb Ischemia, Diabetes
- Interventions
- Edetate Disodium, Placebo
- Drug · Other
- Lead sponsor
- Mt. Sinai Medical Center, Miami
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2027
- U.S. locations
- 1
- States / cities
- Miami Beach, Florida
- Conditions
- Critical Limb Ischemia
- Interventions
- Ticagrelor
- Drug
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 53 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Critical Limb Ischemia, Peripheral Arterial Disease
- Interventions
- disodium EDTA
- Drug
- Lead sponsor
- Mt. Sinai Medical Center, Miami
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- Miami Beach, Florida
- Conditions
- Peripheral Vascular Diseases
- Interventions
- Administration of ERC
- Biological
- Lead sponsor
- Medistem Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Critical Limb Ischemia
- Interventions
- Subjects from Study AG-CLI-0206 who received AMG0001
- Biological
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Critical Limb Ischemia
- Interventions
- Serranator PTA Serration Catheter, PTA (Standard of Care)
- Device · Drug
- Lead sponsor
- Cagent Vascular LLC
- Industry
- Eligibility
- 19 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 2
- States / cities
- New York, New York
- Conditions
- Peripheral Arterial Disease
- Interventions
- Tack Endovascular System
- Device
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 233 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 37
- States / cities
- Yuma, Arizona • Fremont, California • Denver, Colorado + 33 more
- Conditions
- Peripheral Arterial Disease
- Interventions
- Therapeutic Device
- Device
- Lead sponsor
- Vibrato Medical, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Chronic Limb-Threatening Ischemia
- Interventions
- Boomerang Catheter
- Device
- Lead sponsor
- Aveera Medical, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 19
- States / cities
- Sylmar, California • Torrance, California • Whittier, California + 16 more
- Conditions
- Critical Limb Ischemia
- Interventions
- treprostinil dienthanolmine sustained release, Placebo
- Drug
- Lead sponsor
- Ochsner Health System
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Critical Limb Ischemia, Peripheral Vascular Disease, Foot Ulcers, Rest Leg Pain
- Interventions
- Remodulin® (treprostinil sodium) Injection
- Drug
- Lead sponsor
- United Therapeutics
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 7
- States / cities
- Tampa, Florida • Worcester, Massachusetts • Minneapolis, Minnesota + 4 more
- Conditions
- Peripheral Vascular Disease
- Interventions
- Ecraprost in lipid emulsion
- Drug
- Lead sponsor
- Tanabe Pharma Corporation
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 560 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2004
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Glendale, California + 17 more
- Conditions
- Critical Limb Ischemia
- Interventions
- Open surgical revascularization, Endovascular revascularization
- Procedure · Device
- Lead sponsor
- Carelon Research
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,843 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2022
- U.S. locations
- 144
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 102 more
- Conditions
- Critical Limb Ischemia, Vascular Diseases, Peripheral Arterial Disease
- Interventions
- HGF Plasmid
- Biological
- Lead sponsor
- AnGes USA, Inc.
- Industry
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Peripheral Artery Disease
- Interventions
- FlowMet-R, ABI, TBI
- Diagnostic Test
- Lead sponsor
- Medtronic Endovascular
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 195 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2022
- U.S. locations
- 5
- States / cities
- Des Moines, Iowa • Chesterfield, Missouri • New York, New York + 2 more
- Conditions
- Peripheral Artery Disease, Peripheral Vascular Disease, Critical Limb Ischemia
- Interventions
- CD34-positive cells, Saline and 5% autologous plasma
- Biological
- Lead sponsor
- Losordo, Douglas, M.D.
- Individual
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Gainsville, Florida • Orlando, Florida + 9 more
- Conditions
- Chronic Limb-Threatening Ischemia
- Interventions
- MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes
- Device
- Lead sponsor
- Medistim ASA
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Critical Limb Ischemia
- Interventions
- Angioplasty, Laser atherectomy
- Procedure
- Lead sponsor
- Baylor Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 3
- States / cities
- Dallas, Texas • Plano, Texas
- Conditions
- Critical Limb Ischemia (CLI), Peripheral Vascular Disease (PVD)
- Interventions
- Magellan®
- Device
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Peripheral Vascular Diseases
- Interventions
- riferminogene pecaplasmid, Placebo (for riferminogene pecaplasmid)
- Biological
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 525 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2012
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Chronic Limb Threatening Ischemia
- Interventions
- Transverse Tibial Bone Transport, TrueLok Elevate
- Procedure · Device
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Other
- Eligibility
- 18 Years to 95 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
- Interventions
- SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA)
- Device
- Lead sponsor
- M.A. Med Alliance S.A.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 376 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2032
- U.S. locations
- 30
- States / cities
- Chandler, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 26 more